Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study-Reference-Cited by-同舟云学术

Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study

Published:2024-05 Issue:5 Volume:90 Page:1031-1034
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Avallone Gianluca,Mastorino Luca,Tavoletti Gianluca,Macagno Nicole,Barei Francesca,Schena Donatella,Rossi Mariateresa,Magnaterra Elisabetta,Antonelli Flaminia,Babino Graziella,Viola Riccardo,Gargiulo Luigi,Conforti Claudio,Rapparini Luca,Errichetti Enzo,Patruno Cataldo,Ruggiero Pasqualina,Roccuzzo Gabriele,Maronese Carlo A.,Girolomoni Giampiero,Gola Massimo,Chiricozzi Andrea,Balato Anna,Ambrogio Francesca,Narcisi Alessandra,Zalaudek Iris,Gurioli Carlotta,Napolitano Maddalena,Marzano Angelo V.,Foti Caterina,Costanzo Antonio,Piraccini Bianca M.,Ferrucci Silvia M.,Ortoncelli Michela,Quaglino Pietro,Ribero Simone

Publisher

Elsevier BV

Reference5 articles.

1. Characterization of acne associated with upadacitinib treatment in patients with moderate-to-severe atopic dermatitis: A post hoc integrated analysis of 3 phase 3 randomized, double-blind, placebo-controlled trials;Mendes-Bastos;J Am Acad Dermatol,2022

2. Acne among Japanese patients with atopic dermatitis receiving upadacitinib in the phase 3 rising up study;Hayashi;Dermatol Ther (Heidelb),2023

3. Using the common terminology criteria for adverse events (CTCAE - version 5.0) to evaluate the severity of adverse events of anticancer therapies;Freites-Martinez;Actas Dermo-Sifiliogr (Engl),2021

4. Efficacy and safety of upadacitinib treatment in adolescents with moderate-to-severe atopic dermatitis: analysis of the measure up 1, measure up 2, and ad up randomized clinical trials;Paller;JAMA Dermatol,2023

5. Drug-induced acneiform eruption;Du-Thanh;Am J Clin Dermatol,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study;Journal of the European Academy of Dermatology and Venereology;2024-09-09

2. Fungal Head and Neck Dermatitis: Current Understanding and Management;Clinical Reviews in Allergy & Immunology;2024-07-20

3. Etiological Insights of Acne in Atopic Dermatitis Patients under Upadacitinib Treatment: An Exploratory Study;Skin Pharmacology and Physiology;2024-05-03

4. Upadacitinib sustained-release tablets for the treatment of chronic refractory gouty arthritis: a case report and literature review;Frontiers in Medicine;2024-03-28